- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01619202
Comparing Driving Performance Among Trained and Untrained Drivers Using a Driving Simulator
January 23, 2015 updated by: Children's Hospital of Philadelphia
Comparison of Driving Performance Among Trained and Untrained Novice Drivers: Validation of a Multidimensional Simulated Driving Assessment
The purpose of this study is to examine differences in driving performance on a simulated driving assessment between novice teen drivers who receive the Risk Anticipation-Perception Training (RAPT) program and novice teen drivers who do not receive the training program.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Motor vehicle crashes remain the number one cause of death among teens in the United States.
Teen drivers (ages 16 to 19) are four times more likely to be involved in fatal crashes than adult drivers (ages 25 to 69).
Driving simulators are a safer alternative to on-road assessments that are often affordable and can provide experimental control for research.
Though driving simulators have advantages for evaluating driving performance in teens, there are gaps in the literature on the validity of a multidimensional outcome of driving performance in a simulator.
To further examine the validity of a multidimensional measure of driving performance in a simulator, we compare simulated driving performance among teens who are trained hazard anticipation-perception training and those who are not.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Holds a valid driver's license for less than or equal to 180 days
- 16 - 18 years of age
Exclusion Criteria:
- Self-reports claustrophobia, migraine headaches, and/or motion sickness
- Females who are pregnant
- Previously participated in another CHOP driving simulator study
- Non-English Speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Risk Anticipation-Perception Training
Complete the Risk Anticipation-Perception Training (RAPT) program
|
Web-based computer training program designed to teach novice teen drivers how to properly scan for hazards
Other Names:
|
No Intervention: No training program
Does not complete the Risk Anticipation-Perception Training (RAPT) program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Simulated driving performance measured by the number of errors made or the lack thereof, during a series of simulated drives.
Time Frame: at least 1 week after training or enrollment
|
Simulated driving performance will be measured by the number of driving errors made during the simulated drives.
The simulated driving performance will be compared across each arm, Intervention and Control.
Intervention arm: Simulated driving performance will be measured at least 1 week after completion of the RAPT (Hazard Awareness) training program; Control arm: Simulated driving performance will be measured after enrollment and completion of pre-assessment measures.
|
at least 1 week after training or enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Flaura K Winston, MD, PhD, Children's Hospital of Philadelphia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 6, 2012
First Submitted That Met QC Criteria
June 12, 2012
First Posted (Estimate)
June 14, 2012
Study Record Updates
Last Update Posted (Estimate)
January 26, 2015
Last Update Submitted That Met QC Criteria
January 23, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 12-009288
- K99NR013548 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention Harmful Effects
-
Boston Children's HospitalNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedPrevention Harmful EffectsUnited States
-
EuBiologics Co.,LtdInstituto Universitario IVICompletedPrevention Harmful EffectsPhilippines
-
Karolinska InstitutetNot yet recruitingPrevention Harmful EffectsSweden
-
Zurich University of Applied SciencesUniversitat Politècnica de ValènciaCompletedPrevention Harmful Effects
-
M.D. Anderson Cancer CenterWithdrawnCancer | Prevention Harmful Effects
-
University of MiamiNational Institutes of Health (NIH); Patricia and Phillip Frost Museum of Science... and other collaboratorsCompleted
-
Shanghai Changning Maternity & Infant Health HospitalTongji UniversityUnknown
-
University of South CarolinaCompletedPrevention Harmful EffectsUnited States
-
Tel Aviv UniversityIsrael Science FoundationCompletedPrevention Harmful EffectsIsrael
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Unknown
Clinical Trials on Risk Anticipation -Perception Training
-
Istituto per la Ricerca e l'Innovazione BiomedicaRecruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Academy of Sciences; The Driver Training GroupRecruiting
-
Boston VA Research Institute, Inc.RecruitingDevelopmental ProsopagnosiaUnited States
-
Russell L. WoodsResearch to Prevent Blindness / Lions Club International FoundationNot yet recruitingCentral Visual Impairment
-
University of MinnesotaNational Institute of Mental Health (NIMH)RecruitingPsychotic Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Psychosis | Schizo Affective Disorder | Schizophreniform Disorders | Psychoses, Affective | Psychotic Mood Disorders | Psychosis Nos/OtherUnited States
-
Tulane University School of MedicineRobert Wood Johnson FoundationCompletedCervical Cancer | Breast Cancer | Colorectal CancerUnited States
-
Hunan Provincial People's HospitalNot yet recruiting
-
Radboud University Medical CenterCochlearRecruitingDeafness, Bilateral | Deafness Neurosensory | Deafness PermanentNetherlands
-
Stony Brook UniversityActive, not recruiting
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States